Top Institutions in Neurology - Multiple Sclerosis
Leading institutions in MS research employ large-scale randomized controlled trials, advanced neuroimaging, biomarker analysis, and neuroimmunology expertise to evaluate novel therapies such as BTK inhibitors. Their multidisciplinary MS centers integrate clinical neurology, immunology, and rehabilitation to assess disability progression and functional outcomes.
-
#1
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA
Home to the Center for Neuroinflammation and Neurotherapeutics, it is a leader in MS clinical trials and neuroimmunology research, with direct involvement in BTK inhibitor studies and progressive MS therapeutic development.
Key Differentiators
- Neurology
- Neuroimmunology
- Multiple Sclerosis
-
#2
Mayo Clinic
Rochester, MN
Renowned for its comprehensive MS center and pioneering research in progressive MS, Mayo Clinic has a strong track record in clinical trials and biomarker development for disability progression.
Key Differentiators
- Neurology
- Multiple Sclerosis
- Neuroimmunology
-
#3
Cleveland Clinic
Cleveland, OH
Cleveland Clinic’s Mellen Center for MS is a top referral center for progressive MS and has extensive experience in clinical trials of novel agents including immunomodulators and BTK inhibitors.
Key Differentiators
- Neurology
- Multiple Sclerosis
- Clinical Trials
-
#4
Johns Hopkins University School of Medicine
Baltimore, MD
Johns Hopkins has a long-standing MS research program with expertise in neuroimmunology and progressive MS clinical trials, contributing to understanding mechanisms of disability progression.
Key Differentiators
- Neurology
- Neuroimmunology
- Multiple Sclerosis
-
#5
Brigham and Women’s Hospital / Harvard Medical School
Boston, MA
A leading academic center with a multidisciplinary MS program, it has contributed significantly to progressive MS clinical research and development of novel therapeutic agents.
Key Differentiators
- Neurology
- Multiple Sclerosis
- Neuroimmunology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
